Retour aux projets

14576.1;7 PFLS-LS

Oral biomarkers for early diagnosis of fibrotic inflammatory bowel disease (IBD)

Résumé

Oral biomarkers for early diagnosis of fibrotic inflammatory bowel disease (IBD)

Textes supplémentaires

Abstract

We aim at developing a new oral contrast agent for the early diagnosis of fibrotic IBD by means of confocal endomicroscopy. Our imaging agent will be not absorbable, resist digestion in the gut, bind with high specificity to the disease site, and be easily manufactured. Such a tailored IBD probe will be more patient-friendly, making the endoscopic examination less labour intensive, and it would open new horizons in terms of diagnosis and timely treatments.

Participants

Jean-Christophe Leroux

Kontaktperson

jean-christophe.leroux@pharma.ethz.ch

ETH Zürich Jean-Christophe Leroux Wolfgang-Pauli-Strasse 10 8093 Zürich ZH CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2012-10-31
Date de fin
2014-10-22
Coûts totaux approuvés
CHF 294076.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Nicht aufteilbare / nicht zuteilbare Forschung

Disciplines de recherche

  • T490 Biotechnology 100.0%